IL69752A - Pharmaceutical compositions comprising cisplatinum and their preparation - Google Patents

Pharmaceutical compositions comprising cisplatinum and their preparation

Info

Publication number
IL69752A
IL69752A IL69752A IL6975283A IL69752A IL 69752 A IL69752 A IL 69752A IL 69752 A IL69752 A IL 69752A IL 6975283 A IL6975283 A IL 6975283A IL 69752 A IL69752 A IL 69752A
Authority
IL
Israel
Prior art keywords
cisplatinum
preparation
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL69752A
Other languages
English (en)
Other versions
IL69752A0 (en
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of IL69752A0 publication Critical patent/IL69752A0/xx
Publication of IL69752A publication Critical patent/IL69752A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL69752A 1982-09-23 1983-09-16 Pharmaceutical compositions comprising cisplatinum and their preparation IL69752A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento

Publications (2)

Publication Number Publication Date
IL69752A0 IL69752A0 (en) 1983-12-30
IL69752A true IL69752A (en) 1986-07-31

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69752A IL69752A (en) 1982-09-23 1983-09-16 Pharmaceutical compositions comprising cisplatinum and their preparation

Country Status (20)

Country Link
US (1) US4670262A (fr)
JP (1) JPS5978117A (fr)
AT (1) AT382077B (fr)
AU (1) AU559499B2 (fr)
BE (1) BE897761A (fr)
CA (1) CA1211372A (fr)
CH (1) CH655852A5 (fr)
DE (1) DE3333024A1 (fr)
DK (1) DK157168C (fr)
FI (1) FI78236C (fr)
FR (1) FR2533439B1 (fr)
GB (1) GB2127291B (fr)
GR (1) GR79055B (fr)
IE (1) IE56173B1 (fr)
IL (1) IL69752A (fr)
IT (1) IT1153974B (fr)
NL (1) NL8303211A (fr)
SE (1) SE464061B (fr)
SU (1) SU1424722A3 (fr)
ZA (1) ZA836904B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A7 (fi) * 1988-11-14 1990-05-15 Bristol Myers Squibb Co Hypertoninen cisplatin-liuos
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
ATE173627T1 (de) * 1992-09-04 1998-12-15 Fuji Chem Ind Co Ltd Medizinische zusammensetzung
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
CZ302498B6 (cs) * 1999-11-15 2011-06-15 Pharma Mar, S. A. Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
IL155273A0 (en) * 2000-10-12 2003-11-23 Pharma Mar Sa Pharmaceutical compositions comprising an aplidine compound
ES2571219T3 (es) 2001-01-25 2024-09-23 The United States Of America Represented By The Sec Dep Of Health And Human Services Formulación de compuestos de ácido borónico
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
WO2003026642A1 (fr) * 2001-09-21 2003-04-03 Sumitomo Pharmaceuticals Co., Ltd. Preparation pharmaceutique lyophilisee
DE60229414D1 (de) * 2001-10-19 2008-11-27 Pharma Mar Sa Verwendung von aplidine in der behandlung von pankreaskrebs
EP1620117A4 (fr) * 2003-03-12 2009-07-29 Pharma Mar Sa Traitement antitumoraux ameliores
AU2004218883B2 (en) * 2003-03-12 2009-10-01 Dana-Farber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
WO2007101235A2 (fr) * 2006-02-28 2007-09-07 Pharma Mar, S.A. Traitements antitumoraux perfectionnés
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CA2717409A1 (fr) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Traitements ameliores contre le cancer
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
CA2735899A1 (fr) * 2008-09-25 2010-04-01 Cephalon, Inc. Formulations liquides de bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
AU541056B2 (en) * 1980-03-31 1984-12-13 Bristol-Myers Company Pharmaceuticals formulations

Also Published As

Publication number Publication date
SE8304920D0 (sv) 1983-09-13
GB8324380D0 (en) 1983-10-12
AU1908983A (en) 1984-03-29
DK424383A (da) 1984-03-24
IE832172L (en) 1984-03-23
AT382077B (de) 1987-01-12
IT8223396A0 (it) 1982-09-23
CA1211372A (fr) 1986-09-16
FI833300A7 (fi) 1984-03-24
FI78236B (fi) 1989-03-31
GR79055B (fr) 1984-10-02
FI833300A0 (fi) 1983-09-15
FI78236C (fi) 1989-07-10
IT1153974B (it) 1987-01-21
IE56173B1 (en) 1991-05-08
SE8304920L (sv) 1984-03-24
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
ZA836904B (en) 1984-10-31
DK157168C (da) 1990-04-09
FR2533439B1 (fr) 1986-08-14
GB2127291A (en) 1984-04-11
DK424383D0 (da) 1983-09-16
ATA326283A (de) 1986-06-15
IL69752A0 (en) 1983-12-30
FR2533439A1 (fr) 1984-03-30
BE897761A (fr) 1984-01-02
GB2127291B (en) 1986-01-15
AU559499B2 (en) 1987-03-12
JPS5978117A (ja) 1984-05-04
NL8303211A (nl) 1984-04-16
DE3333024A1 (de) 1984-03-29
SE464061B (sv) 1991-03-04
DK157168B (da) 1989-11-20
CH655852A5 (de) 1986-05-30

Similar Documents

Publication Publication Date Title
IL69752A0 (en) Pharmaceutical compositions comprising cisplatinum and their preparation
IL67826A0 (en) Pyrazolooxazines,pyrazolothiazines and pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
DE3468030D1 (en) 13-alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them
IL68421A (en) Pharmaceutical compositions containing oxicam and their preparation
IL68326A0 (en) Arene and hetero-arene carboxamides derivatives,their preparation and pharmaceutical compositions containing them
IL71475A (en) N-aryl-alpha-amino-carboxamides,their preparation and pharmaceutical compositions containing them
IL73951A0 (en) 2-phenyl-imidazoles,their preparation and pharmaceutical compositions containing them
IL68743A0 (en) N-formyl and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides,their preparation and pharmaceutical compositions containing them
IL68497A0 (en) Benzoazacycloalkyl-spiro-imidazolidines,their preparation and pharmaceutical compositions containing them
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
IL68586A0 (en) 4-aryl-4-piperidinecarbinols,their preparation and pharmaceutical compositions containing them
IL68699A (en) 3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
IL71419A0 (en) Phenylaminobenzenealkanols,their preparation and pharmaceutical compositions containing them
IL72307A (en) Pyridinyl-2-pyrimidinamines,their preparation and pharmaceutical compositions containing them
IL70158A (en) Tetrahydronaphthalene-carboxamides,their preparation and pharmaceutical compositions comprising them
IL71110A0 (en) Azolylmethylcycloalkanes,their preparation and pharmaceutical compositions containing them
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
IL71661A0 (en) 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
ZA832811B (en) Azabicyclobenzamides their preparation and their pharmaceutical compositions
GB2146023B (en) Aminocyclopentanes and their preparation and pharmaceutical formulation
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
ZA834539B (en) Pharmaceutical composition and its preparation and use
IL69817A (en) 7-anilinoisoquinoline-5,8-quinones,their preparation and pharmaceutical compositions comprising them
IL69010A (en) 15-alkoxyimino-14-oxoeburnamenines,their preparation and pharmaceutical compositions containing them
IL68190A0 (en) 7-alpha-aminoacyl-3-chlorocephalosporins,their preparation and pharmaceutical compositions containing them